Mass balance, routes of excretion, and pharmacokinetics of investigational oral [14C]-alisertib (MLN8237), an Aurora A kinase inhibitor in patients with advanced solid tumors
2018 ◽
Vol 37
(4)
◽
pp. 666-673
◽
Keyword(s):
2015 ◽
Vol 53
(07)
◽
pp. 563-572
◽
Keyword(s):
Keyword(s):